RecruitingNCT03492424
Ablative Therapy in the Management of Prostate Cancer
Sponsor
Weill Medical College of Cornell University
Enrollment
200 participants
Start Date
Jan 2, 2018
Study Type
OBSERVATIONAL
Conditions
Summary
The purpose of this study is collect observational data regarding patterns of care and outcomes of focal therapies for prostate cancer, including but not limited to: high-intensity focused ultrasound (HIFU), cryotherapy, focal laser ablation, irreversible electroporation, photodynamic therapy, and brachytherapy.
Eligibility
Sex: MALEMin Age: 18 Years
Inclusion Criteria3
- \>18 years of age
- Undergoing focal therapy for primary or salvage treatment of prostate cancer, or
- Have received prior focal therapy
Exclusion Criteria2
- Clinically-evident metastatic disease
- Unable to fill out an English-language questionnaire
Interventions
DEVICEcryotherapy
Subjects will receive focal cryotherapy for treatment of prostate cancer
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03492424
Related Trials
64Cu-SAR-bisPSMA Positron Emission Tomography: A Phase 3 Study of Participants With Biochemical Recurrence of Prostate Cancer
NCT0697084728 locations
Mechanisms of Resistance to PSMA Radioligand Therapy
NCT054354953 locations
Predictors of Mental Health in Men With Prostate Cancer Undergoing a Patient Empowerment Program
NCT0489583916 locations
INSIGHT-PCa: MRI- and PHI-Guided Risk-Adapted Strategy for Prostate Cancer Diagnosis
NCT073986901 location
Enzalutamide and PDS01ADC in PET Positive Recurrent Prostate Cancer (pprPC) Without Testosterone Lowering Therapy
NCT060968701 location